Document is current
Any future updates will be listed below
-
Authors
Annavajhala, Medini K. https://orcid.org/0000-0002-9229-8849
Mohri, Hiroshi https://orcid.org/0000-0003-3101-7625
Wang, Pengfei
Nair, Manoj https://orcid.org/0000-0002-5994-3957
Zucker, Jason E. https://orcid.org/0000-0001-6987-6412
Sheng, Zizhang
Gomez-Simmonds, Angela
Kelley, Anne L.
Tagliavia, Maya
Huang, Yaoxing https://orcid.org/0000-0001-6270-1644
Bedford, Trevor
Ho, David D. https://orcid.org/0000-0003-1627-149X
Uhlemann, Anne-Catrin https://orcid.org/0000-0002-9798-4768
- License Information
-
More Information
Article History
Received: 7 April 2021
Accepted: 13 August 2021
First Online: 24 August 2021
Competing interests
: P.W., M.N., Y.H. and D.D.H. are inventors on a provisional patent application on monoclonal antibodies against SARS-CoV-2. D.D.H. is a member of the scientific advisory board of Brii Biosciences, which has provided a grant to Columbia University to support this and other studies on SARS-CoV-2. A.-C.U. and D.D.H. have received funding from Merck & Co. unrelated to this study.
